← Back to Search

Imaging

Screening Methods for Liver Cancer

N/A

Waitlist Available

Led By Jessica P Hwang

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must be at least 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

Study Summary

This trial is testing a new way to screen for liver fibrosis and cirrhosis. It may help improve survival for patients with liver cancer.

Who is the study for?

This trial is for adults over 18 who can speak and read English or another language with available translation at the HOPE clinic. It's open to new or current patients seeking regular care at the clinic, but pregnant individuals cannot participate.Check my eligibility

What is being tested?

The study is testing how well surveys, blood tests, and a liver scan called Fibroscan can screen for liver fibrosis and cirrhosis in patients. The goal is to find better ways to detect liver cancer early on in people getting care at the HOPE clinic.See study design

What are the potential side effects?

There are minimal side effects expected from this trial as it involves non-invasive procedures like surveys, blood tests, and Fibroscan (similar to an ultrasound). However, some discomfort may occur during blood collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Positive hepatitis B surface antigen test result

Secondary outcome measures

Fibroscan result >= F2

Positive anti-hepatitis C virus (HCV) test result

Trial Design

1Treatment groups

Experimental Treatment

Group I: Screening (survey, biomarker analysis, fibroscan)Experimental Treatment4 Interventions

Patients complete surveys over 10-15 minutes, and undergo blood testing, clinical evaluation, and fibroscan at baseline.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,971 Previous Clinical Trials

1,786,216 Total Patients Enrolled

22 Trials studying Liver Cancer

9,411 Patients Enrolled for Liver Cancer

Cancer Prevention Research Institute of TexasOTHER

50 Previous Clinical Trials

97,438 Total Patients Enrolled

2 Trials studying Liver Cancer

68 Patients Enrolled for Liver Cancer

Jessica P HwangPrincipal InvestigatorM.D. Anderson Cancer Center

3 Previous Clinical Trials

2,258 Total Patients Enrolled

Media Library

Liver Ultrasonographic Elastography (Imaging) Clinical Trial Eligibility Overview. Trial Name: NCT04785534 — N/A

Liver Cancer Research Study Groups: Screening (survey, biomarker analysis, fibroscan)

Liver Cancer Clinical Trial 2023: Liver Ultrasonographic Elastography Highlights & Side Effects. Trial Name: NCT04785534 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment capacity of this medical trial?

"Affirmative, the information accessible on clinicaltrials.gov indicates that this trial is actively enrolling candidates. This study was first listed on December 22nd 2020 and subsequently revised September 22nd 2022. It seeks to recruit 1000 subjects across 1 site."

Answered by AI

Are participants being actively sought for this clinical trial?

"Affirmative, the clinicaltrials.gov page confirms that recruitment is ongoing for this trial which was first published on December 22nd 2020 and most recently updated on September 22nd 2022. 1000 participants are sought at 1 medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

2020. "Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04785534.

All > Liver Cirrhosis > Cirrhosis